Gold nanoparticles show promise in helping restore vision in people with retinal disorders like macular degeneration.

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Research indicates gold nanoparticles could restore eyesight in retinal disease patients, paving the way for non-invasive vision restoration techniques.

Whether you're newly diagnosed with macular degeneration or already in treatment, learn how to make the most of your doctor appointment. This eye disease causes more vision loss than cataracts and ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

An eye check up is more than just about finding vision issues. A thorough eye or retinal scan can, in fact, reveal early ...

Regeneron aims for FDA approval of extended dosing for EYLEA HD in AMD and DME, with a decision by April 2025. Pre-filled ...